Myeloid sarcoma: Current approach and therapeutic options

Therapeutic Advances in Hematology

Volumn 2, Issue 5, 2011, Pages 309-316

  Avni, Batia ^a   Koren Michowitz, Maya ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

acute myeloid leukemia; myeloid sarcoma; prognosis; therapy

Indexed keywords

DNA METHYLTRANSFERASE INHIBITOR; FMS LIKE TYROSINE KINASE 3 INHIBITOR; GEMTUZUMAB OZOGAMICIN; HISTONE DEACETYLASE INHIBITOR; IMATINIB; NUCLEOSIDE ANALOG; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CYTOGENETICS; GRANULOCYTIC SARCOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84993824965     PISSN: 20406207     EISSN: 20406215     Source Type: Journal    
DOI: 10.1177/2040620711410774     Document Type: Review

References (43)

1. Abe R. Umezu H. Uchida T. Kariyone S. Maseki N. Kaneko Y. et al (1986) Myeloblastoma with a 8;21 chromosome translocation in acute myeloblastic leukemia. Cancer 58: 1260–1264.
2. Ansari-Lari M.A. Yang C.-F. Tinawi-Aljundi R. Cooper L. Long P. Allan R.H. et al (2004) FLT 3 mutations in myeloid sarcoma. Br J Haematol 126: 785–791.
3. Avni, B.R., Rund, D., Levin, M., Grisaro, S., Ben-Yehuda, D. and Paltiel, O. (2011) Clinical implications of acute myeloid leukemia presenting as granulocyticsarcoma. Hematol Oncol, in press.
4. Bekassy A.N. Hermans J. Gorin N.C. Gratwohl A. (1996) Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 17: 801–808.
5. Bloomfield C.D. Lawrence D. Byrd J.C. Carroll A. Pettenati M.J. Tantravahi R. et al (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 58: 4173–4179.
6. Burnett A. Wetzler M. Lowenberg B. (2011) Therapeutic advances in acute myeloid leukemia. J Clin Oncol 29: 487–494.
7. Byrd J.C. Weiss R.B. Arthur D.C. Lawrence D. Baer M.R. Davey F. et al (1997) Extramedullary leukaemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from cancer and leukaemia group B 8461. J Clin Oncol 15: 466–475.
8. Chevallier P. Labopin M. Cornelissen J.J. Socié G. Ljungman P.T. Lioure B. et al (2010) Allogeneic stem cell transplantation (allo-SCT) for isolated and leukemic myeloid sarcoma (GS): a survey on behalf of the Acute Leukemia Working Party (ALWP) of EBMT. In ASH Annual Meeting Abstracts.
9. Cunningham I. (2006) Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma 47: 1754–1767.
10. Deeb G. Baer M.R. Gaile D.P. Sait S.N. Barcos M. Wetzler M. et al (2005) Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer 44: 373–383.
11. Dusenbery K.E. Howells W.B. Arthur D.C. Alonzo T. Lee J.W. Kobrinsky N. et al (2003) Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia. J Pediatr Hematol Oncol 25: 760–768.
12. Faaij C.M. Willemze A.J. Revesz T. Balzarolo M. Tensen C.P. Hoogeboom M. et al (2010) Chemokine / chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7. Pediatr Blood Cancer 55: 344–348.
13. Falini B. Lenze D. Hasserjian R. Coupland S. Jaehne D. Soupir C. et al (2007) Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 21: 1566–1570.
14. Finnegan D.P.J. Jones F.G.C. McMullin M.F. (2005) Acute myeloid leukemia with concurrent myeloid sarcoma treated with autologous bone marrow transplantation: two illustrative cases and a literature review. Hematol Oncol 23: 133–135.
15. Imrie K.R. Kovacs M.J. Selby D. Lipton J. Patterson B.J. Pantalony D. et al (1995) Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med 123: 351–353.
16. Jaffe E.S. Harris N.L. Stein H. Vardiman J.W. (2001) Pathology and genetics. In Tumours of Haematopoietic and Lymphoid Tissues, IARC Press: Lyon.
17. Lan T.-Y. Lin D.-T. Tien H.-F. Yang R.-S. Chen C.-Y. Wu K. (2009) Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol 122: 238–246.
18. Meis J.M. Butler J.J. Osborn B.M. Manning J.T. (1986) Granulocytic sarcoma in nonleukemic patients. Cancer 58: 2697–2709.
19. Menasce L.P. Banerjee S.S. Beckett E. Harris M. (1999) Extra-medullary myeloid tumor(granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 34: 391–398.
20. Neiman R.S. Barcos M. Berard C. Bonner H. Mann R. Rydell R.E. et al (1981) Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 48: 1426–1437.
21. Ofran Y. Rowe J.M. (2011) Induction and postremission strategies in acute myeloid leukemia: what is new? Curr Opin Hematol 2: 83–84.
22. Paydas S. Zorludemir S. Ergin M. (2006) Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 47: 2527–2541.
23. Piccaluga P.P. Martinelli G. Rondoni M. Malagola M. Gaitani S. Isidori A. et al (2004) Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas. Leuk Lymphoma 45: 1791–1795.
24. Pileri S.A. Ascani S. Cox M. Campidelli C. Bacci F. Piccioli M. et al (2007) Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21: 340–350.
25. Pui M.H. Fletcher B.D. Langston J.W. (1994) Granulocytic sarcoma in childhood leukemia: imaging features. Radiology 190: 698–702.
26. Roth M.J. Medeiros L.J. Elenitoba-Johnson K. Kuchnio M. Jaffe E.S. Stetler-Stevenson M. (1995) Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. Arch Pathol Lab Med 119: 790–798.
27. Singhal S. Powles R. Kulkarni S. Treleaven J. Saso R. Mehta J. (1999) Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leuk Lymphoma 32: 505–512.
28. Specchia G. Lo Coco F. Vignetti M. Avvisati G. Fazi P. Albano F. et al (2001) Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol 19: 4023–4028.
29. Stefanidakis M. Karjalainen K. Jaalouk D.E. Gahmberg C.G. O'Brien S. Pasqualini R. et al (2009) Role of leukemia cell invadosome in extramedullary infiltration. Blood 114: 3008–3017.
30. Stölzel F. Zoephel K. Röllig C. Radke J. Schetelig J. Platzbecker U. et al (2010) PET-CT scan for detection of extramedullary acute myeloid leukemia. In ASH Annual Meeting Abstracts 2156–2157.
31. Suh Y.K. Shin H.J.C. (2000) Fine-needle aspiration biopsy of granulocytic sarcoma. Cancer 90: 364–372.
32. Swerdlow S.H. Campo E. Harris N.L. Jaffe E.S. Pileri S.A. Stein H. et al (2008) WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, 4th edn. IRAC, 140–141.
33. Swirsky D.M. Li Y.S. Matthews J.G. Flemans R.J. Rees J.K.H. Hayhoe F.G.J. (1984) 8:21 translocation in acute granulocytic leukemia: cytological, cytochemical and clinical features. Br J Haematol 56: 199–213.
34. Szomor A. Passweg J.R. Tichelli A. Hoffmann T. Speck B. Gratwohl A. (1997) Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma(chloroma) after allogeneic bone marrow transplantation. Ann Hematol 75: 239–241.
35. Tallman M.S. Hakimian D. Shaw J.M. Lissner G.S. Russell E.J. Variakojis D. (1993) Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 11: 690–697.
36. Tsimberidou A.M. Kantarjian H.M. Estey E. Cortes J.E. Verstovsek S. Fadrel S. et al (2003) Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 17: 1100–1103.
37. Tsimberidou A.M. Kantarjian H.M. Wen S. Keating M. O'Brien S. Brandt M. et al (2008) Myeloid sarcoma is associated with superior event free survival compared with acute myeloid leukemia. Cancer 113: 1370–1378.
38. Vardiman J.W. Thiele J. Arber D.A. Brunning R.D. Borowitz M.J. Porwit A. et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114: 937–951.
39. Vedy D. Muehlematter D. Rausch T. Stalder M. Jotterand M. Spertini O. (2010) Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib. J Clin Oncol 28: e33–e35.
40. Vega-Ruiz A. Faderl S. Estrov Z. Pierce S. Cortes J. Kantarjian H. et al (2009) Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single institution experience. Int J Hematol 89: 489–496.
41. Wang C. Chen Z. Li Z. Cen J. (2010) The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res 34: 1083–1090.
42. Worch J. Ritter J. Fruhwald M.C. (2008) Presentation of acute promyelocytic leukemia as granulocytic sarcoma. Pediatr Blood Cancer 50: 657–660.
43. Yamauchi K. Yasuda M. (2002) Comparison in treatments of nonleukemic granulocytic sarcoma: report of 2 cases and a review of 72 cases in the literature. Cancer 94: 1739–1746.